EMG-biofeedback in muscular dystrophy

Not Applicable

• Conditions: Muscular dystrophy.; G71.00 - Muscular dystrophy, unspecified; G71.00

• Registration Number: IRCT20200326046864N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Muscular dystrophy with proximal muscles involvement
Approved muscular dystrophy diagnosis by neurologist
Ability to walk 10 meters without help
To be volunteer for intervention

Exclusion Criteria

Using drugs affecting muscular strength
Acute myositis
Orthopedic problems limiting patient movements
Other neurologic or systemic disease involving muscles
Skin lesion or infection at the site of electrode placements
History of symptomatic cardiomyopathy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Muscle strength. Timepoint: before intervention, after 6 weeks intervention, 3 months post intervention. Method of measurement: dynamometer.

Secondary Outcome Measures

Name	Time	Method
Motor Function. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: The Motor Function Measure-32 scale.;Fatigue severity. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: Fatigue severity scale.;Balance. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: Berg Balance Scale.;Quality of life. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: SF-36 for quality of life evaluation.